Evidence-based medicine in migraine prophylactic treatment in childhood and adolescence

Umberto Balottin, Matteo Ferri, Cristiano Termine

Research output: Contribution to journalArticle

Abstract

(Table Presented) Migraine is a common and disabling disorder, affecting children, adolescents, and adults. Prophylactic therapy should be considered when specific clinical conditions are fulfilled. Its goal is to reduce the frequency and duration of the attacks as well as the severity of pain, thus allowing patients to regain routine activities and ameliorating their quality of life. Using the principles of evidence-based medicine, a review of available published data on the efficacy and safety of prophylactic treatments for migraine in children and adolescents is presented. Currently, only flunarizine and psychologically based interventions (e.g., relaxation training, biofeedback, and psychotherapeutic techniques) may be effective in migraine prophylaxis in children and adolescents. Owing to the paucity of evidence, there is a need for large, controlled, randomized, and masked trials. Clinical researchers should consider that migraine, especially in childhood and adolescence, is a complex condition, resulting from the interaction between biological, psychological, and environmental factors. Specific events, constitutional predisposition, individual and environmental-emotional dynamics can play a significant role in the genesis and evolution of pain. Age-related characteristics such as prevalence, diagnosis, quality of life, and therapy should be considered designing future studies.

Original languageEnglish
Pages (from-to)461-468
Number of pages8
JournalDrug Development Research
Volume68
Issue number7
DOIs
Publication statusPublished - Dec 2007

Fingerprint

Biofeedback
Flunarizine
Regain
Evidence-Based Medicine
Migraine Disorders
Medicine
Quality of Life
Pain
Therapeutics
Randomized Controlled Trials
Research Personnel
Psychology
Safety

Keywords

  • Adolescence
  • Childhood
  • Evidence-based
  • Migraine
  • Prophylactic treatment
  • Review

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Pharmacology

Cite this

Evidence-based medicine in migraine prophylactic treatment in childhood and adolescence. / Balottin, Umberto; Ferri, Matteo; Termine, Cristiano.

In: Drug Development Research, Vol. 68, No. 7, 12.2007, p. 461-468.

Research output: Contribution to journalArticle

@article{548d13182a7a481b82367fa55df4bc16,
title = "Evidence-based medicine in migraine prophylactic treatment in childhood and adolescence",
abstract = "(Table Presented) Migraine is a common and disabling disorder, affecting children, adolescents, and adults. Prophylactic therapy should be considered when specific clinical conditions are fulfilled. Its goal is to reduce the frequency and duration of the attacks as well as the severity of pain, thus allowing patients to regain routine activities and ameliorating their quality of life. Using the principles of evidence-based medicine, a review of available published data on the efficacy and safety of prophylactic treatments for migraine in children and adolescents is presented. Currently, only flunarizine and psychologically based interventions (e.g., relaxation training, biofeedback, and psychotherapeutic techniques) may be effective in migraine prophylaxis in children and adolescents. Owing to the paucity of evidence, there is a need for large, controlled, randomized, and masked trials. Clinical researchers should consider that migraine, especially in childhood and adolescence, is a complex condition, resulting from the interaction between biological, psychological, and environmental factors. Specific events, constitutional predisposition, individual and environmental-emotional dynamics can play a significant role in the genesis and evolution of pain. Age-related characteristics such as prevalence, diagnosis, quality of life, and therapy should be considered designing future studies.",
keywords = "Adolescence, Childhood, Evidence-based, Migraine, Prophylactic treatment, Review",
author = "Umberto Balottin and Matteo Ferri and Cristiano Termine",
year = "2007",
month = "12",
doi = "10.1002/ddr.20215",
language = "English",
volume = "68",
pages = "461--468",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Evidence-based medicine in migraine prophylactic treatment in childhood and adolescence

AU - Balottin, Umberto

AU - Ferri, Matteo

AU - Termine, Cristiano

PY - 2007/12

Y1 - 2007/12

N2 - (Table Presented) Migraine is a common and disabling disorder, affecting children, adolescents, and adults. Prophylactic therapy should be considered when specific clinical conditions are fulfilled. Its goal is to reduce the frequency and duration of the attacks as well as the severity of pain, thus allowing patients to regain routine activities and ameliorating their quality of life. Using the principles of evidence-based medicine, a review of available published data on the efficacy and safety of prophylactic treatments for migraine in children and adolescents is presented. Currently, only flunarizine and psychologically based interventions (e.g., relaxation training, biofeedback, and psychotherapeutic techniques) may be effective in migraine prophylaxis in children and adolescents. Owing to the paucity of evidence, there is a need for large, controlled, randomized, and masked trials. Clinical researchers should consider that migraine, especially in childhood and adolescence, is a complex condition, resulting from the interaction between biological, psychological, and environmental factors. Specific events, constitutional predisposition, individual and environmental-emotional dynamics can play a significant role in the genesis and evolution of pain. Age-related characteristics such as prevalence, diagnosis, quality of life, and therapy should be considered designing future studies.

AB - (Table Presented) Migraine is a common and disabling disorder, affecting children, adolescents, and adults. Prophylactic therapy should be considered when specific clinical conditions are fulfilled. Its goal is to reduce the frequency and duration of the attacks as well as the severity of pain, thus allowing patients to regain routine activities and ameliorating their quality of life. Using the principles of evidence-based medicine, a review of available published data on the efficacy and safety of prophylactic treatments for migraine in children and adolescents is presented. Currently, only flunarizine and psychologically based interventions (e.g., relaxation training, biofeedback, and psychotherapeutic techniques) may be effective in migraine prophylaxis in children and adolescents. Owing to the paucity of evidence, there is a need for large, controlled, randomized, and masked trials. Clinical researchers should consider that migraine, especially in childhood and adolescence, is a complex condition, resulting from the interaction between biological, psychological, and environmental factors. Specific events, constitutional predisposition, individual and environmental-emotional dynamics can play a significant role in the genesis and evolution of pain. Age-related characteristics such as prevalence, diagnosis, quality of life, and therapy should be considered designing future studies.

KW - Adolescence

KW - Childhood

KW - Evidence-based

KW - Migraine

KW - Prophylactic treatment

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=38849173837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38849173837&partnerID=8YFLogxK

U2 - 10.1002/ddr.20215

DO - 10.1002/ddr.20215

M3 - Article

AN - SCOPUS:38849173837

VL - 68

SP - 461

EP - 468

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

IS - 7

ER -